Entitled “WKMO Global Leadership Series 2014”, the forum was held in Sao Paulo Hilton on Feb. 6 attending by more than 100 physicians, including Dr. Chul Soo Hyun , President of World Korean Medical Organization(WKMO), Dr. David Ko, president of Korean American Medical Association (KAMA), Dr. Heejung Kang, president of Korean Paraguay Medical Association(AMCP), Dr. Taemo Jeong, vice president of Korean Brazilian Medical Association(KOBRAMA), and other WKMO board member physicians from Korea, US, Brazil, UK and Australia.

 

In his congratulatory remarks, Ambassador to Brazil Bonwoo Koo said, “It is very much meaningful to see Korean physicians all around the world gathering together not only to remember their root but also discuss ways to contribute to Korea.” “I ask all [Korean] physicians to help support the success of Korean technology and products in Brazilian market where needs for medical areas are high.”

 

Especially, President Claudio Lottenberg, the Chairman of ‘Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein’ which is Brazil’s largest hospital Einstein Group at the event stated that “I have much admiration for Korea and confidence for its technology. I will enthusiastically consider Korean products that are ready to reach Forum Held in San Paulo... Attended by 100 Plus Korean Physicians Largest Brazilian Hospital Group, Enthusiastic for Possible Acquisition of Korean Medical Products World Korean Medical Organization (WKMO) held an international medical industry forum and discussed the collaboration between Korea and Brazil.” Additionally, Korean Brazilian physicians such as Dr. Sangchun Cha who twice served as president of the Brazilian Ultrasound Society of nearly two million members to Dr. Dongwon Lee, professor of Sao Paulo University of Medicine to and the first Korean Brazilian physician Dr. Youngman Lee promised at the event to assist Korean companies entry into Brazil via various channels, including Brazilian politicians and medical institutes.

 

Wonyoung Lee, President of Vatech Brazil, confirmed a recent successful completion of onsite inspection by ANVISA’s GMP and expressed his hope for positive outcome given Einstein Group’s interest in purchase itself is valuable.

 

As part of the forum, technologies and products by several Korean pharmaceutical companies for hopeful entry into Brazil were introduced.

This event, hosted by WKMO and organized by W Medical Strategy Group, was concluded on Feb. 8th.